The bill H.209 amends existing legislation regarding the administration of epinephrine in schools, specifically expanding the scope to include intranasal epinephrine alongside epinephrine auto-injectors. It introduces new definitions, such as "intranasal epinephrine" and updates the definition of "designated personnel" to include practical nurses. The bill allows health care professionals to prescribe both forms of epinephrine for schools and mandates that schools maintain a stock supply of these medications. It also outlines the responsibilities of school nurses and designated personnel in administering these medications during emergencies, ensuring that they are trained and authorized to act in such situations.

Additionally, the bill provides legal immunity for designated personnel, schools, and health care professionals from civil or criminal liability when administering epinephrine, unless intentional misconduct is proven. It requires the State Board, in consultation with the Department of Health, to adopt policies for managing life-threatening allergies in schools, including protocols for preventing allergen exposure and responding to allergic reactions. The act is set to take effect on July 1, 2025.

Statutes affected:
As Introduced: 16-1388
As Passed By the House -- Official: 16-1388
As Passed By the House -- Unofficial: 16-1388